Search Results 791-800 of 17078 for egfr

  1. Publications - Gregory Frey, M.D. - Mayo Clinic

    De la Garza-Ramos C, Bussone S, Adams LL, Barber MD, Frey GT, Lewis AR, Paz-Fumagalli R, Toskich BB. Expediting care for hepatocellular carcinoma View ...

  2. Open-Label extension study of Saroglitazar Magnesium in Participants with Primary Biliary Cholangitis - Mayo Clinic

    eGFR < 45 mL/min/1.73 m2; ALT or AST > 250 U/L x ULN; ALP > 10 × ULN. Participation in another interventional clinical study and receipt of any other ...

  3. Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer - Mayo Clinic

    ... EGFR tyrosine kinase inhibitor, or with trastuzumab emtansine (T-DM1), trastuzumab deruxtecan (T-DXd), or any other HER2-directed antibody-drug conjugate.

  4. A Study to Evaluate M7824 with Concurrent Chemoradiation (cCRT) in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

    Participants with tumor harboring an EGFR sensitizing (activating) mutation, ALK translocation, ROS-1 rearrangement are eligible. These tests are not ...

  5. Publications - Andre M. Oliveira, M.D., Ph.D. - Mayo Clinic

    MET and EGFR mutations identified in ALK-rearranged pulmonary adenocarcinoma: molecular analysis of 25 ALK-positive cases. J Thorac Oncol. 2013 May; 8(5): ...

  6. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    5× ULN or estimated glomerular filtration rate (eGFR, Modification of Diet in Renal Disease [MDRD] formula) ≥0 mL/min/1.73m2;; Albumin ≥ g/dL;; Amylase and ...

  7. Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty - Mayo Clinic

    Patients with advanced renal insufficiency (i.e., chronic kidney disease (CKD) Stage 4 or 5 or patients with an estimated glomerular filtration rate (eGFR) <30 ...

  8. Publications - Isabel O. Cortopassi, M.D. - Mayo Clinic

    EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small cell lung cancer. Ann Oncol. 2019; 30(8):1311-1320.. Haas BM, Hahn ...

  9. A Study of Ibubilast in Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    ... eGFR < 30 mL/min/1.73m2, thyroid-stimulating hormone (TSH) levels >10 mIU/L or <0.01 mIU/L. 3. Active drug or alcohol abuse 4. Female patient is lactating ...

  10. A Study to Evaluate Abemaciclib to Treat Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration - Mayo Clinic

    Estimated Creatinine Clearance (CrCl) ≥ 30 mL/min (Cockcroft-Gault), estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m^2 (MDRD or CKD-EPI ...